脑微出血急性卒中患者溶栓治疗的研究进展

脑微出血患者发生急性卒中事件时，在时间窗内给予溶栓治疗是十分具有挑战的临床决 策。如果给予溶栓治疗，出血的风险较高；不给予溶栓治疗，可能使时间窗内的卒中患者错过最佳治 疗的时机。研究发现，并不是所有的脑微出血急性卒中患者在接受溶栓治疗后都会发生出血，如果 可以明确导致出血的危险因素，就能识别出适合溶栓的脑微出血患者，从而采取有针对性的治疗措 施使患者受益。

Research Progress of Thrombolytic Therapy in Stroke Patients with Cerebral Microbleeds

It is a very challenging clinical decision for cerebral microbleeds in patients with acute stroke events to receive thrombolytic therapy. If given thrombolysis treatment, there will be a higher risk of bleeding. If do not give thrombolysis treatment, it may cause stroke patients missing the best timing of treatment within the time window. Studies have found that not all the patients with acute stroke and cerebral microbleeds had hemorrhage after having been treated with thrombolysis. If the risk factors for causing bleeding could be clarified, patients with cerebral microbleeds who are suitable for thrombolysis could be distinguished so as to take different treatment measures to benefit the patients.